KR900009593A - 2-클로로피리딘 3-카르복실산 에스테르 제조 방법 - Google Patents
2-클로로피리딘 3-카르복실산 에스테르 제조 방법 Download PDFInfo
- Publication number
- KR900009593A KR900009593A KR1019890017985A KR890017985A KR900009593A KR 900009593 A KR900009593 A KR 900009593A KR 1019890017985 A KR1019890017985 A KR 1019890017985A KR 890017985 A KR890017985 A KR 890017985A KR 900009593 A KR900009593 A KR 900009593A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- group
- optionally substituted
- hydrogen atom
- halogen atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 하기 일반식(Ⅱ)의 부타디엔 유도체 :5-1(상기 식에서, R1은 임의로 치환된 알킬, 알케닐, 알키닐 또는 시클로알킬기를 나타내고; R2는 수소원자 또는 임의로 치환된 알킬 또는 알콕시기를 나타내고; R3및 R4는 독립적으로 수소원자 또는 임의로 치환된 알킬 또는 알콕시기를 나타내거나 R3및 R4가 함께, 임의로 치환된 알킬렌기를 나타내고; R5및 R6은 독립적으로 수소원자 또는 임의로 치환된 알킬, 알케닐, 알키닐, 시클로알킬 또는 아릴기를 나타내거나 중간의 질소 원자와 함께 임의로 치환된 복소환식 고리를 나타낸다)를 염화수소와 반응시키는 것을 특징으로 하는, 하기 일반식(Ⅰ)의 2-클로로피리딘 3-카르복실산 에스테르 제조 방법 :5-2상기식에서, R1, R2, R3및 R4는 상기한 바와같다.
- 제1항에 있어서, R1은 각각의 기가 할로겐 원자, C1-4알콕시, 페닐 및 나프틸기 중에서 선택된 하나 이상의 치환체에 의해 임의로 치환된 C1-10알킬, C2-10알케닐 또는 C2-10알키닐기: 또는 할로겐 원자, C1-4알킬 및 C1-4알콕시기 중에서 선택된 하나이상의 치환체에 의해 임의로 치환된 C3-10시클로알킬기를 나타내고; R2는 수소원자 또는 각각의 기가 하나 이상의 할로겐 원자에 의해 임의로 치환된 C1-6알킬 또는 C1-6알콕시기를 나타내고; R3및 R4는 독립적으로 수소 원자 또는 각각의 기가 하나 이상의 할로겐 원자에 의해 임의로 치환된 C1-6알킬 또는 C1-6알콕시기를 나타내거나, R3및 R4가 함께, 하나 이상의 할로겐 원자에 의해 임의로 치환된 알킬렌기 -(CH2)- (여기서, n은 1~8의 정수이다)를 나타내고; R5및 R6은 독립적으로 수소원자; 각각의 기가 할로겐원자, C1-4알콕시, 페닐 및 나프틸기 중에서 선택된 하나 이상의 치환체에 의해 임의로 치환된 C1-10알킬, C2-10알케닐 또는 C2-10알키닐기; 또는 각각의 기가 할로겐 원자, C1-4알킬 및 C1-4알콕시기 중에서 선택된 하나 이상의 치환체에 의해 임의로 치환된 C3-10시클로알킬, 페닐 또는 나프틸기를 나타내거나; 중간의 질소 원자와 함께 R5및 R6가 부가적인 이종원자를 임의로 함유하고 할로겐 원자 C1-4알킬 및 C1-4알콕시기 중에서 선택된 하나 이상의 치환체에 의해 임의로 치환된 5-또는 6-원 복소환식 고리를 나타내는 것을 특징으로 하는 방법.
- 제1항 또는 제2항에 있어서, R1은 C1-4알킬기를 나타내고 ; R2는 수소원자 또는 C1-4알킬 또는 C1-4알콕시기를 나타내고; R3및 R4는 독립적으로 수소원자 또는 C1-4알킬 또는 C1-4알콕시기를 나타내거나 R3및 R4가 함께 알킬렌기 -(CH2)n- (여기서, n은 2-6의 정수이다)를 나타내고; R5및 R6은 독립적으로 수소원자 또는 C1-4알킬 또는 C1-4알킬 또는 페닐기를 나타내거나 중간의 질소 원자와 함께 5- 또는 6-원 복소환식고리를 나타내는 것을 특징으로 하는 방법.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 극성 또는 비-극성 용매 존재하에 반응이 수행되는 것을 특징으로 하는 방법.
- 제4항에 있어서, 용매가 메탄올, 에탄올, n-프로판올, 이소프로판올, n-부탄올 및 이소부탄올 중에서 선택되는 것을 특징으로 하는 방범.
- 제1항 내지 제5항 중 어느 한 항에 있어서, 일반식(Ⅱ)의 화합물이 현장에서 제조되는 것을 특징으로 하는 방법.
- 제1항 내지 제6항 중 어느 한 항에 있어서 과량의 염화수소 존재하에 반응이 수행되는 것을 특징으로 하는 방법.
- 제1항 내지 제7항 중 어느 한 항에 있어서 O℃-100℃에서 반응이 수행되는 것을 특징으로 하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3840954.2 | 1988-12-05 | ||
DE3840954A DE3840954A1 (de) | 1988-12-05 | 1988-12-05 | Herstellung von 2-chlornicotinsaeureestern |
Publications (1)
Publication Number | Publication Date |
---|---|
KR900009593A true KR900009593A (ko) | 1990-07-05 |
Family
ID=6368493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890017985A KR900009593A (ko) | 1988-12-05 | 1989-12-05 | 2-클로로피리딘 3-카르복실산 에스테르 제조 방법 |
Country Status (9)
Country | Link |
---|---|
US (1) | US4987232A (ko) |
EP (1) | EP0372654A3 (ko) |
JP (1) | JPH02200674A (ko) |
KR (1) | KR900009593A (ko) |
BR (1) | BR8906200A (ko) |
CA (1) | CA2004583A1 (ko) |
DE (1) | DE3840954A1 (ko) |
DK (1) | DK612789A (ko) |
IL (1) | IL92545A0 (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0462639A1 (en) * | 1990-06-05 | 1991-12-27 | Shell Internationale Researchmaatschappij B.V. | Preparation of 2-chloropyridine derivatives |
US5235060A (en) * | 1991-07-11 | 1993-08-10 | E. I. Du Pont De Nemours And Company | Certain three component ionic substituted pyridine compounds as intermediates for preparation as herbicides |
US5229519A (en) * | 1992-03-06 | 1993-07-20 | Reilly Industries, Inc. | Process for preparing 2-halo-5-halomethylpyridines |
DE19834565A1 (de) * | 1998-07-31 | 2000-02-03 | Basf Ag | Verfahren zur Herstellung von 2-Halogennikotinsäurederivaten sowie neue 2-Chlornikotinsäureester |
AU2006272978B2 (en) | 2005-07-26 | 2012-06-07 | Bial - Portela & Ca, S.A. | Nitrocatechol derivatives as COMT inhibitors |
EP1845097A1 (en) | 2006-04-10 | 2007-10-17 | Portela & Ca., S.A. | Oxadiazole derivatives as COMT inhibitors |
DK2481410T3 (en) | 2007-01-31 | 2016-10-24 | Bial - Portela & Ca S A | Nitrocatecholderivater as COMT inhibitors administered in a specific dosage regimen |
US20100292482A1 (en) * | 2007-10-24 | 2010-11-18 | BIAL -Portela & CA.., S.A. | Novel precursors |
MX2010009610A (es) | 2008-03-17 | 2010-09-30 | Bial Portela & Ca Sa | Formas de cristal de 5-[3-(2,5-dicloro-4,6-dimetil-1-oxi-piridin-3 -il)-[1,2,4]oxadiazol-5-il]-3-nitrobenceno-1,2-diol. |
WO2009141759A1 (en) | 2008-05-19 | 2009-11-26 | Koninklijke Philips Electronics N.V. | Noise robust helper data system (hds) |
CN101367760B (zh) * | 2008-10-08 | 2010-12-29 | 南开大学 | 2-氯烟酸的合成方法 |
WO2010114404A1 (en) | 2009-04-01 | 2010-10-07 | Bial - Portela & Ca., S.A. | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof |
US20140045900A1 (en) | 2011-02-11 | 2014-02-13 | Bial-Portela & Ca, S.A. | Administration regime for nitrocatechols |
KR102023789B1 (ko) * | 2011-07-21 | 2019-09-20 | 바스프 에스이 | 메로시아닌 유도체 |
EP2734499B1 (en) * | 2011-07-21 | 2020-06-24 | Basf Se | Merocyanine derivatives |
JP6456143B2 (ja) | 2011-12-13 | 2019-01-23 | ノヴィファーマ,エス.アー. | カテコール−o−メチル転移酵素阻害剤を調製するための中間体として有用な化学的化合物 |
CN102993092A (zh) * | 2012-12-05 | 2013-03-27 | 江苏拜克新材料有限公司 | 一种2-氯烟酸的合成方法 |
CN105636938B (zh) * | 2013-10-11 | 2018-09-07 | Lg化学株式会社 | 制备3-烷硫基-2-溴吡啶的方法 |
CN104876861B (zh) * | 2014-02-27 | 2017-05-24 | 上海泰禾国际贸易有限公司 | 一种生产2‑氯烟酸的方法 |
RU2017120184A (ru) | 2014-11-28 | 2018-12-28 | БИАЛ - ПОРТЕЛА ЭНД Ка, С.А. | Лекарства для замедления течения болезни паркинсона |
CN104803982A (zh) * | 2015-04-20 | 2015-07-29 | 安徽久易农业股份有限公司 | 一种烟嘧磺隆的制备方法 |
WO2023173214A1 (en) * | 2022-03-18 | 2023-09-21 | University Of Saskatchewan | One step synthesis of 1-tetralone compounds and uses thereof in the preparation of (+)-tetralone abscisic acid (aba) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH617680A5 (ko) * | 1976-04-02 | 1980-06-13 | Lonza Ag | |
JPS5576863A (en) * | 1978-12-06 | 1980-06-10 | Yoshitomi Pharmaceut Ind Ltd | Preparation of 2-chloronicotinic acid |
JPS58213760A (ja) * | 1982-06-07 | 1983-12-12 | Ishihara Sangyo Kaisha Ltd | クロロニコチン酸系化合物の製造方法 |
JPS59144759A (ja) * | 1983-02-07 | 1984-08-18 | Yuki Gosei Yakuhin Kogyo Kk | 2−クロロニコチン酸の製造方法 |
-
1988
- 1988-12-05 DE DE3840954A patent/DE3840954A1/de not_active Withdrawn
-
1989
- 1989-12-05 DK DK612789A patent/DK612789A/da not_active Application Discontinuation
- 1989-12-05 CA CA002004583A patent/CA2004583A1/en not_active Abandoned
- 1989-12-05 BR BR898906200A patent/BR8906200A/pt not_active Application Discontinuation
- 1989-12-05 KR KR1019890017985A patent/KR900009593A/ko not_active Application Discontinuation
- 1989-12-05 JP JP1314502A patent/JPH02200674A/ja active Pending
- 1989-12-05 IL IL92545A patent/IL92545A0/xx not_active IP Right Cessation
- 1989-12-05 US US07/446,135 patent/US4987232A/en not_active Expired - Fee Related
- 1989-12-05 EP EP19890203083 patent/EP0372654A3/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
BR8906200A (pt) | 1990-09-25 |
DK612789D0 (da) | 1989-12-05 |
CA2004583A1 (en) | 1990-06-05 |
DK612789A (da) | 1990-06-06 |
DE3840954A1 (de) | 1990-06-07 |
JPH02200674A (ja) | 1990-08-08 |
EP0372654A3 (en) | 1991-04-17 |
IL92545A0 (en) | 1990-08-31 |
US4987232A (en) | 1991-01-22 |
EP0372654A2 (en) | 1990-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900009593A (ko) | 2-클로로피리딘 3-카르복실산 에스테르 제조 방법 | |
DK164451C (da) | 3-aminoquinolinderivat | |
KR860000272A (ko) | 헤테로아릴옥시아세트아미드의 제조방법 | |
KR890005084A (ko) | 퀴놀린 유도체 | |
KR860003241A (ko) | 피페리딘 유도체의 제조방법 | |
KR840003618A (ko) | 2-시아노벤즈 이미다졸 유도체의 제조방법 | |
KR870001199A (ko) | 헤테로시클릭 화합물의 제조방법 | |
KR850002103A (ko) | 세팔로스포린의 제조방법 | |
KR850008165A (ko) | 헤테로사이클릭 유도체의 제조방법 | |
EA200000484A1 (ru) | Способ получения производных тиазолидиндиона | |
KR840006482A (ko) | 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법 | |
KR840001177A (ko) | 제초제인 설폰아미드의 제조방법 | |
KR860001065A (ko) | 4-아세톡시-3-히드록시에틸아제티진-2-온유도체의 제조방법 | |
KR880011122A (ko) | 4-티오퀴나졸린 유도체, 이의 제조방법 및 약제학적 조성물 | |
KR860003272A (ko) | 펩타이드-치환된-헤테로사이클릭 화합물의 제조방법 | |
KR890011856A (ko) | 1-알킬-5-니트로이미다졸의 제조방법 | |
KR850006176A (ko) | (아릴티오) 피리딜 알칼올 유도체의 제조방법 | |
KR860006472A (ko) | 신규 세팔로스포린의 제조 방법 | |
KR920014798A (ko) | 카밤산 유도체 및 이의 제조방법 | |
KR840005723A (ko) | 티아졸유도체의 제조방법 | |
KR870007902A (ko) | 복소환식 화합물 | |
KR870007142A (ko) | 이환 화합물의 제조방법 | |
KR850002257A (ko) | 1-아조릴-치환된 옥심 에테르의 제조방법 | |
KR840004089A (ko) | 구아니디노 헤테로사이클릭페닐아미딘의 제조방법 | |
KR840007002A (ko) | β-락탐 유도체의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |